Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for plausibility
When do you file for a drug combination invention? (T592/24) When do you file for a drug combination invention? (T592/24) Reviewed by Dr Rose Hughes on Monday, June 22, 2026 Rating: 5
Fordham 33 (Report 4): Life sciences and healthcare innovation Fordham 33 (Report 4): Life sciences and healthcare innovation Reviewed by Annsley Merelle Ward on Tuesday, April 14, 2026 Rating: 5
Sufficiency at the priority date: A study protocol is not "the same" as a therapeutic effect invention (T0883/23) Sufficiency at the priority date: A study protocol is not "the same" as a therapeutic effect invention (T0883/23) Reviewed by Dr Rose Hughes on Wednesday, October 29, 2025 Rating: 5
Patentee's own post-published data undermines the credibility of their broad cat antibody patent (T 0709/23) Patentee's own post-published data undermines the credibility of their broad cat antibody patent (T 0709/23) Reviewed by Dr Rose Hughes on Wednesday, October 22, 2025 Rating: 5
Event report: C5 Pharma & Biotech Patent Litigation in Europe (Day 1), Plausibility, UPC and antibody IP strategy Event report: C5 Pharma & Biotech Patent Litigation in Europe (Day 1), Plausibility, UPC and antibody IP strategy Reviewed by Dr Rose Hughes on Tuesday, May 27, 2025 Rating: 5
UK court reaffirms its stringent plausibility standard in AstraZeneca despite G 2/21 UK court reaffirms its stringent plausibility standard in AstraZeneca despite G 2/21 Reviewed by Annsley Merelle Ward on Friday, May 09, 2025 Rating: 5
The plausibility of diagnostic inventions: No data, no patent (T 0589/22) The plausibility of diagnostic inventions: No data, no patent (T 0589/22) Reviewed by Dr Rose Hughes on Tuesday, April 29, 2025 Rating: 5
Never Too Late: If you missed the IPKat last week! Never Too Late: If you missed the IPKat last week! Reviewed by Asude Sena Moya on Monday, January 27, 2025 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.